Patents by Inventor Kenneth J. Piller

Kenneth J. Piller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170342426
    Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independant transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.
    Type: Application
    Filed: August 7, 2017
    Publication date: November 30, 2017
    Inventors: Toni Armstrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
  • Publication number: 20160024512
    Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independent transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.
    Type: Application
    Filed: September 23, 2015
    Publication date: January 28, 2016
    Inventors: Toni Armstrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
  • Patent number: 9175298
    Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independent transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.
    Type: Grant
    Filed: September 18, 2007
    Date of Patent: November 3, 2015
    Assignee: Monsanto Technology LLC
    Inventors: Toni Armstrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
  • Patent number: 7960610
    Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independent transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.
    Type: Grant
    Filed: September 18, 2007
    Date of Patent: June 14, 2011
    Assignee: Monsanto Technology LLC
    Inventors: Toni Armstrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
  • Patent number: 7858370
    Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independent transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.
    Type: Grant
    Filed: September 18, 2007
    Date of Patent: December 28, 2010
    Assignee: Monsanto Technology LLC
    Inventors: Toni Armstrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
  • Patent number: 7288694
    Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independant transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.
    Type: Grant
    Filed: July 5, 2002
    Date of Patent: October 30, 2007
    Assignee: Monsanto Technology LLC
    Inventors: Toni Armstrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
  • Patent number: 7195917
    Abstract: Methods and materials are disclosed for the inhibition and control of gibberellic acid levels. In particular, nucleic acid sequences of copalyl diphosphate synthase. 3-? hydroxylase, and 2-oxidase and additional nucleic acid sequences are disclosed. Gibberellic acid levels may be inhibited or controlled by preparation of a chimeric expression construct capable of expressing a RNA or protein product which suppresses the gibberellin biosynthetic pathway sequence, diverts substrates from the pathway or degrades pathway substrates or products. The sequence is preferably a copalyl diphosphate synthase sequence, a 3?-hydroxylase sequence, a 2-oxidase sequence, a phytoene synthase sequence, a C20-oxidase sequence, and a 2?,3?-hydroxylase sequence. Administration of a complementing agent, preferably a gibberellin or gibberellin precursor or intermediate restores bioactivity.
    Type: Grant
    Filed: March 27, 2003
    Date of Patent: March 27, 2007
    Assignee: Monsanto Technology LLC
    Inventors: Sherri M. Brown, Tedd D. Elich, Gregory R. Heck, Ganesh M. Kishore, Eugene W. Logusch, Sherry J. Logusch, Kenneth J. Piller, Sudabathula Rao, Joel E. Ream, Scott R. Baerson
  • Patent number: 6723897
    Abstract: Methods and materials are disclosed for the inhibition and control of gibberellic acid levels. In particular, nucleic acid sequences of copalyl diphosphate synthase, 3-&bgr; hydroxylase, and 2-oxidase and additional nucleic acid sequences are disclosed. Gibberellic acid levels may be inhibited or controlled by preparation of a chimeric expression construct capable of expressing antisense RNA which suppresses the gibberellin biosynthetic pathway sequence. The antisense sequence is the complement of a copalyl diphosphate synthase sequence, a 3&bgr;-hydroxylase sequence, or a C20-oxidase sequence. Administration of a complementing agent, preferably a gibberellin or gibberellin precursor or intermediate restores bioactivity.
    Type: Grant
    Filed: August 10, 1999
    Date of Patent: April 20, 2004
    Assignee: Monsanto Technology, LLC
    Inventors: Sherri M. Brown, Tedd D. Elich, Gregory R. Heck, Ganesh M. Kishore, Eugene W. Logusch, Sherry J. Logusch, Kenneth J. Piller, Sudabathula Rao, Joel E. Ream, Scott R. Baerson
  • Publication number: 20030233679
    Abstract: Methods and materials are disclosed for the inhibition and control of gibberellic acid levels. In particular, nucleic acid sequences of copalyl diphosphate synthase. 3-&bgr; hydroxylase, and 2-oxidase and additional nucleic acid sequences are disclosed. Gibberellic acid levels may be inhibited or controlled by preparation of a chimeric expression construct capable of expressing a RNA or protein product which suppresses the gibberellin biosynthetic pathway sequence, diverts substrates from the pathway or degrades pathway substrates or products. The sequence is preferably a copalyl diphosphate synthase sequence, a 3&bgr;-hydroxylase sequence, a 2-oxidase sequence, a phytoene synthase sequence, a C20-oxidase sequence, and a 2&bgr;,3&bgr;-hydroxylase sequence. Administration of a complementing agent, preferably a gibberellin or gibberellin precursor or intermediate restores bioactivity.
    Type: Application
    Filed: March 27, 2003
    Publication date: December 18, 2003
    Applicant: Monsanto Technology LLC.
    Inventors: Sherri M. Brown, Tedd D. Elich, Gregory R. Heck, Ganesh M. Kishore, Eugene W. Logusch, Sherry J. Logusch, Kenneth J. Piller, Sudabathula Rao, Joel E. Ream, Scott R. Baerson
  • Publication number: 20030110532
    Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independant transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.
    Type: Application
    Filed: July 5, 2002
    Publication date: June 12, 2003
    Inventors: Toni Armostrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
  • Publication number: 20020053095
    Abstract: Methods and materials are disclosed for the inhibition and control of gibberellic acid levels. In particular, nucleic acid sequences of copalyl diphosphate synthase, 3-&bgr; hydroxylase, and 2-oxidase and additional nucleic acid sequences are disclosed. Gibberellic acid levels may be inhibited or controlled by preparation of a chimeric expression construct capable of expressing a RNA or protein product which suppresses the gibberellin biosynthetic pathway sequence, diverts substrates from the pathway or degrades pathway substrates or products. The sequence is preferably a copalyl diphosphate synthase sequence, a 3&bgr;-hydroxylase sequence, a 2-oxidase sequence, a phytoene synthase sequence, a C20-oxidase sequence, and a 2&bgr;,3&bgr;-hydroxylase sequence. Administration of a complementing agent, preferably a gibberellin or gibberellin precursor or intermediate restores bioactivity.
    Type: Application
    Filed: August 10, 1999
    Publication date: May 2, 2002
    Applicant: ARNOLD WHITE & DURKEE
    Inventors: SHERRI M. BROWN, TEDD D. ELICH, GREGORY R. HECK, GANESH M. KISHORE, EUGENE W. LOGUSCH, SHERRY J. LOGUSCH, KENNETH J. PILLER, SUDABATHULA RAO, JOEL E. REAM